Treatment

• 

  Treating Smoldering Multiple Myeloma

  A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.

  by Sandra Gordon

• 

  Immunotherapy Improves Survival in Bladder Cancer

  New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.

  by Laura Gesualdi-Gilmore

• 

  Delaying Treatment Resistance

  Adding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.

  by Thomas Celona

• 

  2024: The Year in Cancer News

  The Cancer Today editors share the most impactful reporting on cancer research from 2024.

  by Cancer Today staff

• 

  Forward Look

  Stem Cell Transplant Rates Decrease for Lymphoma

  More patients are receiving CAR T-cell therapy for large B-cell lymphoma.

  by Leah Lawrence

• 

  Forward Look

  Rethinking Cancer Drug Doses

  Researchers and patients push to move away from maximum tolerated dose in research.

  by Natalie Slivinski

• 

  Reducing the Burden of Radiation

  Shorter courses of more intense radiation therapy mean fewer visits and less cost for patients. Studies show abbreviated treatments are just as effective as longer courses.

  by Stephen Ornes

• 

  Making Their Mark

  With targeted therapy options available for a growing number of cancer types, biomarker testing is making a difference for more people with solid cancers.

  by Kendall K. Morgan

• 

  Cancer Care for Older Adults

  Geriatric assessments can help physicians and older patients choose effective treatments with fewer side effects.

  by Eric Fitzsimmons

• 

  Forward Look

  Cognition and Prostate Cancer

  Androgen deprivation therapy, a common prostate cancer treatment, may increase cognitive difficulties.

  by Joseph Jalkiewicz